JPH0225477U

JPH0225477U -

Info

Publication number: JPH0225477U
Application number: JP10426988U
Authority: JP
Priority date: 1988-08-06
Filing date: 1988-08-06
Publication date: 1990-02-20

Description

[Brief explanation of drawings]

第１〜６図は本考案緩衝シートの概念を説明す
る図で、第１図はキヤツプフイルムとバツクフイ
ルムとよりなる気泡シートのバツクフイルム側に
ウエブを用いて薬剤収容した場合の断面図で、第
１図ａは主に合成樹脂フイルムで気泡シートを形
成した緩衝シート、第１図ｂはガスバリア性フイ
ルムで気泡シートを形成した緩衝シート、第２図
はキヤツプフイルム、バツクフイルム、ライナフ
イルムよりなる気泡シートのバツクフイルム側も
しくはライナフイルム側にウエブを用いて薬剤収
容した場合の断面図で、第２図ａは主に合成樹脂
フイルムで気泡シートを形成した緩衝シート、第
２図ｂはガスバリア性フイルムで気泡シートを形
成した緩衝シート、第３図は発泡ポリエチレンシ
ートにウエブを用いて薬剤を収容した場合の断面
図、第４〜６図は薬剤収容を例示する図で、第４
図ａは錠剤収容の正面図、第４図ｂは第４図ａの
Ａ―Ａ断面図、第５図ａは粒状薬剤収容の正面図
、第５図ｂは第５図ａのＡ―Ａ断面図、第６図ａ
は粉末状薬剤収容の正面図、第６図ｂは第６図ａ
のＡ―Ａ断面図、第７〜９図は従来技術を例示す
る断面図で、第７図は封入法、第８図は練込法、
第９図は谷部充填法を示す。１は気泡シート、１１は発泡ポリエチレンシー
ト、２１はキヤツプフイルム、２２はバツクフイ
ルム、２３はライナフイルム、２４はガスバリア
層、２５は接着性ポリオレフイン層、２６は低密
度ポリエチレン保護層、３はウエブ、３１は孔、
４は薬剤、４１は島、５は接合部、５１は粘着剤
などの接着剤、６は薬剤練込フイルムを示す。 Figures 1 to 6 are diagrams explaining the concept of the buffer sheet of the present invention, and Figure 1 is a cross-sectional view of a bubble sheet consisting of a cap film and a back film, in which a drug is housed on the back film side using a web. Figure 1a shows a buffer sheet mainly made of synthetic resin film, Figure 1b shows a buffer sheet made of gas barrier film, and Figure 2 shows cap film, back film, and liner film. This is a cross-sectional view of a case where a web is used to store drugs on the back film side or liner film side of a bubble sheet. Figure 2a is a buffer sheet in which the bubble sheet is mainly made of synthetic resin film, and Figure 2b is a gas barrier sheet. 3 is a cross-sectional view of a foamed polyethylene sheet containing a drug using a web; FIGS. 4 to 6 are diagrams illustrating drug accommodation;
Figure a is a front view of tablet storage, Figure 4b is a sectional view taken along line A-A in Figure 4a, Figure 5a is a front view of granular drug storage, and Figure 5b is line A-A in Figure 5a. Cross-sectional view, Figure 6a
is a front view of powdered drug storage, Figure 6b is Figure 6a
Figures 7 to 9 are cross-sectional views illustrating conventional techniques, where Figure 7 shows the encapsulation method, Figure 8 shows the kneading method,
FIG. 9 shows the valley filling method. 1 is a foam sheet, 11 is a foamed polyethylene sheet, 21 is a cap film, 22 is a back film, 23 is a liner film, 24 is a gas barrier layer, 25 is an adhesive polyolefin layer, 26 is a low density polyethylene protective layer, 3 is a web, 31 is a hole;
4 is a drug, 41 is an island, 5 is a joint, 51 is an adhesive such as a pressure-sensitive adhesive, and 6 is a drug-mixed film.

Claims

[Claims for Utility Model Registration] (1) A cell sheet made of a cap film having many convex portions and a flat back film,
A buffer sheet characterized in that a web is adhered to a back film side, and a drug is accommodated between the back film and the web. (2) The buffer sheet according to claim 1, wherein the cap film and the back film both have gas barrier properties. (3) A web is adhered to the back film side or liner film side of a bubble sheet formed of a cap film having many convex portions, a flat back film, and a flat liner film, and the web is bonded to the back film or liner film. A buffer sheet characterized by accommodating a drug between the layers. (4) The buffer sheet according to claim 3, wherein the cap film and the back film both have gas barrier properties. (5) A buffer sheet characterized by adhering a web to a foamed polyethylene sheet and storing a drug between the foamed polyethylene sheet and the web.